$15.19
0.53 (+3.62%)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)
CAPS Rating:
The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.
RSS Headlines
Fool UK